Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$2.60 – $6.99
12% from low
Exchange
OTC Link
CS
CANSINO BIOLGICS REG H
No one on the platform currently holds CASBF.
No tracked institution reports a position in CASBF as of their last filing.
No one on the platform has traded CASBF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $1.5B | +40.5% | $0.53 | $0.50–$0.56 | 6.0× | 1 |
| 2027 | $1.9B | +24.6% | $1.44 | $1.37–$1.53 | 2.2× | 1 |
| 2028 | $2.4B | +28.4% | $2.05 | $1.96–$2.18 | 1.5× | 1 |
| 2029 | $2.8B | +19.2% | $3.73 | $3.56–$3.97 | 0.8× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 7 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-03-30 | $0.04 | $0.01 | -82.4% |
| 2025-10-27 | $-0.00 | $0.02 | +2476.9% |
| 2025-08-20 | $-0.01 | $-0.00 | +92.1% |
| 2025-04-29 | $-0.00 | $-0.01 | -3335.0% |
| 2024-12-31 | $-0.02 | $-0.09 | -324.9% |
| 2024-10-29 | $-0.05 | $0.00 | +103.5% |
| 2024-08-29 | $-0.05 | $-0.03 | +39.8% |